Back to search

Article

Association of RAS mutations with early progression after first-line systemic therapy in patients with initially unresectable colorectal cancer liver metastasis

2021-11-01

Abstract excerpt

<title>Abstract</title> <p>Purpose Patients with initially unresectable colorectal cancer with liver metastases (IU-CRLM) need to undergo first-line systemic therapy with the aid of chemotherapy. However, the driver gene attributed to early progression in IU-CRLM patients after first-line systemic therapy remains unclear. Our study explored the RAS mutation status related to early progression in IU-CRLM patients...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bb3f4ad6-bf71-5259-8b8c-743d2d271bc9
DOI
10.21203/rs.3.rs-1016958/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association of RAS mutations with early progression after first-line systemic therapy in patients with initially unresectable colorectal cancer liver metastasisDOI 10.21203/rs.3.rs-1016958/v1
Oncological Outcomes of Patients with Peritoneal Metastasis–only Colorectal Cancer Treated with First-line Bevacizumab and FOLFIRI through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis–only, and Lung Metastasis–onlySemantic proximity
First-line treatment efficacy and prognostic model in RAS-mutant metastatic colorectal cancer: a real-world study.Semantic proximity
BRAF Mutation Drives Early Multifocal Intrahepatic Recurrence after Curative Resection of Liver-Limited Colorectal Metastases.Semantic proximity
RAS mutation associated with short surgically controllable period in colorectal liver metastases: a retrospective study.Semantic proximity
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.Semantic proximity
Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.Semantic proximity
RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastasesSemantic proximity
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.Semantic proximity
Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.Semantic proximity
RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.Semantic proximity
RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.Semantic proximity
A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.Semantic proximity
Select a neighboring publication to make it the new centre.